Results 31 to 40 of about 1,567,257 (239)

Concurrent inhibition of FAK/SRC and MEK overcomes MEK inhibitor resistance in Neurofibromatosis Type I related malignant peripheral nerve sheath tumors

open access: yesFrontiers in Oncology, 2022
Malignant peripheral nerve sheath tumors (MPNST) are aggressive soft-tissue sarcomas which lack effective drugs. Loss of the RAS GTPase-activating protein NF1 and subsequent overactivation of mitogen-activated protein kinase kinase (MAPK) signaling exist
Yihui Gu   +10 more
semanticscholar   +1 more source

Giant plexiform neurofibroma of lower limb: Importance of radiology in diagnosis, complications and management

open access: yesIbom Medical Journal, 2022
Plexiform neurofibromatosis is reported to occur in 26.7% of patients with type I neurofibromatosis. Plexiform neurofibromas present at, or soon after, birth as areas of hyperpigmentation, thickening of the skin and excess hair.
Udeagu GC, Njeze NR, Ukwuaku CC
doaj   +1 more source

Hyperpigmented spots at fundus examination: a new ocular sign in Neurofibromatosis Type I

open access: yesOrphanet Journal of Rare Diseases, 2020
Background Neurofibromatosis Type I (NF1), also termed von Recklinghausen disease, is a rare genetic disorder that is transmitted by autosomal dominant inheritance, with complete penetrance and variable expressivity.
A. Moramarco   +7 more
semanticscholar   +1 more source

Giant intrthoracic meningoceles associated with cutaneous neurofibromatosis type I: case report [PDF]

open access: yesArquivos de Neuro-Psiquiatria, 2003
BACKGROUND: Intrathoracic meningocele is a rare pathology, almost always associated with neurofibromatosis type I and with a few cases related in the literature.
Guilherme Cabral de Andrade   +5 more
doaj   +1 more source

Notching in the Posterior Border of the Ramus of Mandible in a Patient with Neurofibromatosis Type I – A Case Report [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2013
Neurofibromatosis Type I (NFI) is a relatively common hereditary, autosomal dominant neurocutaneous condition. It is a benign peripheral nerve sheath tumour arising from Schwann cells and peripheral fibroblasts.
Bhuvana Krishnamoorthy   +4 more
doaj   +1 more source

Pediatric PK/PD Phase I Trial of Pexidartinib in Relapsed and Refractory Leukemias and Solid Tumors Including Neurofibromatosis Type I related Plexiform Neurofibromas

open access: yesClinical Cancer Research, 2020
Purpose: Simultaneously targeting the tumor and tumor microenvironment may hold promise in treating children with refractory solid tumors. Pexidartinib, an oral inhibitor of tyrosine kinases including colony stimulating factor 1 receptor (CSF-1R), KIT ...
Lauren H Boal   +13 more
semanticscholar   +1 more source

Computed Tomography–Based Differentiation of Benign and Malignant Craniofacial Lesions in Neurofibromatosis Type I Patients: A Machine Learning Approach

open access: yesFrontiers in Oncology, 2020
Background: Because neurofibromatosis type I (NF1) is a cancer predisposition disease, it is important to distinguish between benign and malignant lesions, especially in the craniofacial area.
Chengjiang Wei   +13 more
semanticscholar   +1 more source

Neurofibroma of the Palate

open access: yesCase Reports in Dentistry, 2014
Neurofibroma is a benign peripheral nerve sheath tumor comprising variable mixture of Schwann cells, perineurial-like cells, and fibroblasts. Neurofibroma may occur as solitary lesion or as part of a generalised syndrome of neurofibromatosis or very ...
Tirumalasetty Sreenivasa Bharath   +5 more
doaj   +1 more source

Risk factors for intraoperative hemorrhage of Type I neurofibromatosis

open access: yesBMC Surgery, 2023
Introduction Neurofibromatosis (NF) is an inherited disease and a benign tumor originating from nerve sheath cells. Neurofibromatosis type I (NF1) is the most common type, and most cases are characterized by neurofibromas. Neurofibromas in NF1 are mainly
Qianqian Gao   +6 more
doaj   +1 more source

The neurofibromatosis type I gene promotes autophagy via mTORC1 signalling pathway to enhance new bone formation after fracture

open access: yesJournal of Cellular and Molecular Medicine, 2020
Bone fracture is one of the most common injuries. Despite the high regenerative capacity of bones, failure of healing still occurs to near 10% of the patients.
Q. Tan   +8 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy